Exercise testing in the prognostic evaluation of patients with lung and heart diseases

Louis Laviolette, Pierantonio Laveneziana

Source: Eur Respir Monogr 2018; 80: 222-234

Journal Issue: Clinical Exercise Testing

Disease area: Pulmonary vascular diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Louis Laviolette, Pierantonio Laveneziana. Exercise testing in the prognostic evaluation of patients with lung and heart diseases. Eur Respir Monogr 2018; 80: 222-234

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Exercise testing in the prognostic evaluation of patients with lung and heart diseases Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-49-5, page=195 Year: 2007
Exercise testing in lung disease Source: Course 2015 - Clinical exercise testing Year: 2015
Exercise testing in lung disease Source: School Course 2013 - Clinical exercise testing Year: 2013
Exercise testing in interstitial lung disease diagnosis and management Source: Eur Respir Mon; 2009: 46: 7 Year: 2009
Predictive factors of lung function in patients with COPD and heart failure Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020
Non-invasive biomarkers for the evaluation of a patient at risk for lung cancer Source: Annual Congress 2013 –Early detection of lung cancer Year: 2013
The prognostic value of cardiopulmonary exercise testing in interstitial lung disease: a systematic review Source: ERJ Open Res, 6 (3) 00027-2020; 10.1183/23120541.00027-2020 Year: 2020
Prevalence and underdiagnosis of COPD in patients with ischemic heart disease demonstrated by coronary angiography. Prognostic implications Source: International Congress 2015 – COPD: notable points Year: 2015
The role of cardiopulmonary exercise testing in assessment of the severity of patients with PAH associated with congenital heart disease. Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019
Noninvasive assessment in the evaluation of occupational lung diseases Source: Annual Congress 2009 - MP8 - Noninvasive assessment in the evaluation of occupational lung diseases Year: 2009
Lung function testing for the preoperative evaluation of patients with lung cancer Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients Year: 2003
Cardiopulmonary exercise test as prognostic tool in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases Year: 2007
Exercise testing in lung and heart transplantation Source: Annual Congress 2004 - PG16 - Contemporary dimensions in cardiopulmonary exercise testing and interpretation Year: 2004
Exercise testing in cardiovascular diseases Source: Annual Congress 2003 - PG17 - Contemporary dimensions in cardiopulmonary exercise testing and interpretation Year: 2003
Prevalence and impact of small airways dysfunction in patients with ischemic heart disease Source: International Congress 2014 – Pathophysiological mechanisms at different scales Year: 2014